Inspire Medical Systems, Inc.
INSP
$52.07
-$0.09-0.17%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 911.98M | 882.62M | 861.31M | 840.11M | 802.80M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 911.98M | 882.62M | 861.31M | 840.11M | 802.80M |
| Cost of Revenue | 133.23M | 133.14M | 133.77M | 128.94M | 122.99M |
| Gross Profit | 778.76M | 749.48M | 727.55M | 711.17M | 679.82M |
| SG&A Expenses | 624.64M | 604.19M | 575.71M | 548.28M | 529.61M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 861.03M | 845.90M | 819.91M | 790.30M | 766.72M |
| Operating Income | 50.95M | 36.73M | 41.40M | 49.82M | 36.08M |
| Income Before Tax | 65.70M | 52.01M | 58.79M | 71.97M | 58.45M |
| Income Tax Expenses | -79.73M | 7.46M | 5.67M | 5.46M | 4.94M |
| Earnings from Continuing Operations | 145.42 | 44.56 | 53.12 | 66.51 | 53.51 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 145.42M | 44.56M | 53.12M | 66.51M | 53.51M |
| EBIT | 50.95M | 36.73M | 41.40M | 49.82M | 36.08M |
| EBITDA | 64.91M | 49.34M | 52.19M | 58.57M | 42.63M |
| EPS Basic | 5.02 | 1.50 | 1.78 | 2.23 | 1.79 |
| Normalized Basic EPS | 1.50 | 1.27 | 1.32 | 1.51 | 1.22 |
| EPS Diluted | 4.98 | 1.46 | 1.72 | 2.16 | 1.72 |
| Normalized Diluted EPS | 1.48 | 1.24 | 1.28 | 1.47 | 1.18 |
| Average Basic Shares Outstanding | 117.48M | 118.37M | 118.92M | 119.14M | 119.05M |
| Average Diluted Shares Outstanding | 118.64M | 120.17M | 121.20M | 122.11M | 121.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |